Global Virology V: 21st Century Vaccines and Viruses

Paul Shapshak, PhD, is an Adjunct Professor in the Department of Internal Medicine, Division of Infectious Diseases and International Health, University of South Florida, Morsani College of Medicine, in Tampa, Florida, USA. His background is in molecular biology, virology, neuro-immunology, and drug abuse research.Setharam Balaji, PhD, is an Associate Professor (Sr. Scale) in the Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka-576104, India.  His background is in biochemistry, bioinformatics, and drug design. Pandjassaramme Kangueane, PhD, is the Director of Biomedical Informatics Private Limited, India and is the Chief Editor of Bioinformation, an open access journal in Biological Knowledge Discovery, India. His research interest is in HLA based short peptide vaccine design and in protein-protein interactions.Jens Kuhn, MD, PhD, is lead virologist at the Integrated Research Facility, part of the National Interagency Biodefense Campus at the NIH/NIAID. He specializes in highly virulent viral pathogens. Charurut Somboonwit, MD, is a Professor in the Department of Internal Medicine, Division of Infectious Diseases and International Health, University of South Florida, Morsani College of Medicine, in Tampa, Florida, USA. . Her expertise is in communicable diseases and HIV medicine.John T. Sinnott, MD, is in the Department of Internal Medicine at the University of South Florida Morsani College of Medicine, and the Director of the Florida Infectious Disease Institute. His expertise is in infectious diseases.

• 1-15. Individual virus vaccines  (Nipah, Hendra/Nipah/Henipaviridae peptides, Circovirus, Hantavirus, Prion, Influenza, Zika, Venezuelan EEV, HIV, etc.).- 16. Cut-across vaccines.- 17. Strategies in vaccine development and testing.- 18. Prior and anticipated barriers to vaccines.- 19. Sociological and psychiatric barriers to vaccines.- 20. International issues and barriers in vaccine development and promulgation.- 21. Clinical applications of vaccine development, promulgation, and testing.- 22. Applications of CRISPR.- 23. Applications of siRNA.- 24. Nano-molecular vaccine adjuvant technology.-  25. Vaccine development in education.- 26. The intersection of animal, avian, and insect worlds.- 27. Honeybee discrimination.- 28. Jumping genes in maize.- 29. Exclusion of gene expression.